-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PW8faesl+j7nUwIndXyo00wLGnH/TXzsp0lKhURDQbc88vazwWw3PfmLnZtnOWkW 8eiYuWQOLX9KNklabF7jJw== 0001232524-09-000024.txt : 20091127 0001232524-09-000024.hdr.sgml : 20091126 20091125184034 ACCESSION NUMBER: 0001232524-09-000024 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091127 DATE AS OF CHANGE: 20091125 EFFECTIVENESS DATE: 20091127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JAZZ PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001232524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 050563787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-55145 FILM NUMBER: 091209274 BUSINESS ADDRESS: STREET 1: 3180 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-496-3777 MAIL ADDRESS: STREET 1: 3180 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 D/A 1 primary_doc.xml X0603 D/A LIVE 0001232524 JAZZ PHARMACEUTICALS INC 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777 DELAWARE None None Corporation true Bruce C. Cozadd c/o Jazz Pharmaceuticals, Inc. 3180 Porter Drive Palo Alto CA 94304 Executive Officer Director Robert M. Myers c/o Jazz Pharmaceuticals, Inc. 3180 Porter Drive Palo Alto CA 94304 Executive Officer Director Samuel D. Colella c/o Versant Ventures 3000 Sand Hill Road, #4-210 Menlo Park CA 94025 Director Michael W. Michelson c/o Kohlberg Kravis Roberts & Co. 2800 Sand Hill Road, Suite 200 Menlo Park CA 94025 Director James C. Momtazee c/o Kohlberg Kravis Roberts & Co. 2800 Sand Hill Road, Suite 200 Menlo Park CA 94025 Director Patrick G. Enright c/o Longitude Capital 800 El Camino Real, Suite 220 Menlo Park CA 94025 Director Kenneth W. O'Keefe c/o Beecken Petty O'Keefe & Company, LLC 131 South Dearborn Street, Suite 2800 Chicago IL 60603 Director James B. Tananbaum c/o Prospect Venture Partners 435 Tasso Street, Suite 200 Palo Alto CA 94301 Director Alan M. Sebulsky c/o Apothecary Capital LLC 1 North Wacker Drive, Suite 3950 Chicago IL 60606 Director Bryan C. Cressey c/o Thoma Cressey Bravo Sears Tower, 92nd Fl., 22 S. Wacker Dr. Chicago IL 60606 Director Carol A. Gamble c/o Jazz Pharmaceuticals, Inc. 3180 Porter Drive Palo Alto CA 94304 Executive Officer Janne L.T. Wissel c/o Jazz Pharmaceuticals, Inc. 3180 Porter Drive Palo Alto CA 94304 Executive Officer Joan E. Colligan c/o Jazz Pharmaceuticals, Inc. 3180 Porter Drive Palo Alto CA 94304 Executive Officer Nathaniel M. Zilkha c/o Kohlberg Kravis Roberts & Co. 2800 Sand Hill Road, Suite 200 Menlo Park CA 94025 Director Pharmaceuticals Decline to Disclose 06 true 9999999997-05-032438 2005-06-24 false true true true true Offering of $80.0 million principal amount of Senior Secured Notes ("Notes"), warrants to purchase 785,728 shares of Common Stock ("Warrants") and the underlying shares of Common Stock issuable upon exercise of Warrants. false 0 87338700 80000000 7338700 Item 13(a) represents the principal amount of the Notes sold on 6/24/05 and the current aggregate exercise price of the related Warrants issued on 6/24/05. On 11/10/09, the per share exercise price of the Warrants was reduced from $20.36 to $9.34. false 12 0 0 0 false JAZZ PHARMACEUTICALS INC /s/ Carol A. Gamble Carol A. Gamble Senior Vice President, General Counsel and Secretary 2009-11-25 -----END PRIVACY-ENHANCED MESSAGE-----